Ontogeny of drug-metabolizing enzymes and its influence on the pathogenesis of adverse drug reactions in children
- 1 December 2001
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 62 (12) , 900-912
- https://doi.org/10.1016/s0011-393x(01)80094-1
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Neonatal paroxetine withdrawal syndromeArchives of Disease in Childhood: Fetal & Neonatal, 2001
- Onset of xenobiotic metabolism in children: Toxicological implicationsFood Additives & Contaminants, 1998
- Selective Serotonin Reuptake Inhibitor-Induced Serotonin SyndromeJournal of Clinical Psychopharmacology, 1997
- Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation.Environmental Health Perspectives, 1997
- Cytochrome P450 in Human Fetal Liver: Significance and Fetal-Specific ExpressonDrug Metabolism Reviews, 1994
- Associations Between Risk Factors for Valproate Hepatotoxicity and Altered Valproate MetabolismEpilepsia, 1992
- Fatal Liver Failure in 16 Children with Valproate TherapyEpilepsia, 1988
- Evaluation of a scheme for establishing and maintaining dosage of theophylline in ambulatory patients with chronic asthmaThe Journal of Pediatrics, 1986
- Free Concentration of Carbamazepine and Carbamazepine-10,11-Epoxide in Children and AdultsClinical Pharmacokinetics, 1985
- Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patientThe Journal of Pediatrics, 1980